Literature DB >> 17261277

Reliability of 1,9-dimethylmethylene blue tests in comparison to agarose gel electrophoresis for quantification of urinary glycosaminoglycans.

Cilene R de Lima1, Raquel Y A Baccarin, Yara M Michelacci.   

Abstract

BACKGROUND: The relevance of glycosaminoglycan determination in biological fluids is gradually gaining importance in the literature. Nevertheless, the results obtained by different methods vary widely. We evaluated 1,9-dimethylmethylene blue (DMB) dye-binding assays for quantification of urinary glycosaminoglycans, in comparison to densitometry after agarose gel electrophoresis.
METHODS: Urinary glycosaminoglycans from different mammalian species were quantified by 3 different DMB dye-binding assays. The results were compared to those obtained by densitometry after agarose gel electrophoresis of glycosaminoglycans isolated from urine samples by ion exchange chromatography.
RESULTS: Densitometry after agarose gel electrophoresis showed glycosaminoglycan urinary concentrations of 1-20 mg/l, and glycosaminoglycan/creatinine ratios of 2-25x10(-3), for all the mammalian species here studied. A decrease with age was observed for humans, cats and horses. In comparison, DMB assays gave much higher results - up to 200 mg/l and 500x10(-3) glycosaminoglycan/creatinine ratios. These values were greatly reduced after 4-h dialysis, suggesting that low molecular weight compounds do interfere. Furthermore, urinary anions such as sulfate, phosphate and citrate, react with metachromatic dyes, such as Toluidine Blue and DMB.
CONCLUSION: DMB assays, although rapid and simple, are not appropriate to quantify urinary glycosaminoglycans in normal mammalians, since other urinary components interfere with the reactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17261277     DOI: 10.1016/j.cca.2006.11.025

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Fluorescent liposomes for differential interactions with glycosaminoglycans.

Authors:  Erin K Nyren-Erickson; Manas K Haldar; Yan Gu; Steven Y Qian; Daniel L Friesner; Sanku Mallik
Journal:  Anal Chem       Date:  2011-06-30       Impact factor: 6.986

2.  Plasmatic and Urinary Glycosaminoglycans Characterization in Mucopolysaccharidosis II Patient Treated with Enzyme-Replacement Therapy with Idursulfase.

Authors:  Giovanni V Coppa; Dania Buzzega; Lucia Zampini; Francesca Maccari; Lucia Santoro; Fabio Galeotti; Tiziana Galeazzi; Orazio Gabrielli; Nicola Volpi
Journal:  JIMD Rep       Date:  2011-11-04

3.  Relevance of synovial fluid chondroitin sulphate as a biomarker to monitor polo pony joints.

Authors:  Raquel Y A Baccarin; Luciane Rasera; Thaís S L Machado; Yara M Michelacci
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

4.  The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome.

Authors:  Bilal Firat Alp; Ilker Akyol; Cuneyt Adayener; Temucin Senkul; Mustafa Gultepe; Kadir Baykal; Cuneyt Iseri
Journal:  Int Urol Nephrol       Date:  2008-09-16       Impact factor: 2.370

5.  Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification.

Authors:  Chiara Paganini; Luca Monti; Rossella Costantini; Roberta Besio; Silvia Lecci; Marco Biggiogera; Kun Tian; Jean-Marc Schwartz; Céline Huber; Valérie Cormier-Daire; Beth G Gibson; Katarzyna A Pirog; Antonella Forlino; Antonio Rossi
Journal:  Matrix Biol       Date:  2018-11-12       Impact factor: 11.583

6.  Microanalysis, Pharmacokinetics and Tissue Distribution of Polysaccharide-Protein Complexes from Longan Pulp in Mice.

Authors:  Ting Min; Jie Sun; Yang Yi; Hong-Xun Wang; Fei Hang; You-Wei Ai; Li-Mei Wang
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.